Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.

Marbaix S, Peetermans WE, Verhaegen J, Annemans L, Sato R, Mignon A, Atwood M, Weycker D.

PLoS One. 2018 Jul 6;13(7):e0199427. doi: 10.1371/journal.pone.0199427. eCollection 2018.

2.

Appropriateness of end-of-life care in people dying from COPD. Applying quality indicators on linked administrative databases.

De Schreye R, Smets T, Deliens L, Annemans L, Gielen B, Cohen J.

J Pain Symptom Manage. 2018 Jun 27. pii: S0885-3924(18)30334-8. doi: 10.1016/j.jpainsymman.2018.06.011. [Epub ahead of print]

PMID:
29960021
3.

Resource use during the last 6 months of life among COPD patients: a population level study.

Faes K, Cohen J, Annemans L.

J Pain Symptom Manage. 2018 Jun 11. pii: S0885-3924(18)30295-1. doi: 10.1016/j.jpainsymman.2018.06.002. [Epub ahead of print]

PMID:
29902554
4.

Hospital financing of ischaemic stroke: determinants of funding and usefulness of DRG subcategories based on severity of illness.

Dewilde S, Annemans L, Pincé H, Thijs V.

BMC Health Serv Res. 2018 May 11;18(1):356. doi: 10.1186/s12913-018-3134-6.

5.

Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.

Zeymer U, Annemans L, Danchin N, Pocock S, Newsome S, Van de Werf F, Medina J, Bueno H.

Eur Heart J Acute Cardiovasc Care. 2018 Apr 1:2048872618769057. doi: 10.1177/2048872618769057. [Epub ahead of print]

PMID:
29611427
6.

Strategies for newborn screening for cystic fibrosis: A systematic review of health economic evaluations.

Schmidt M, Werbrouck A, Verhaeghe N, De Wachter E, Simoens S, Annemans L, Putman K.

J Cyst Fibros. 2018 May;17(3):306-315. doi: 10.1016/j.jcf.2018.03.002. Epub 2018 Mar 20. Review.

PMID:
29572018
7.

Achieving estimated health and budget gains through combined HIV prevention: theoretical results require real-world effort.

Vermeersch S, Callens S, De Wit S, Goffard JC, Van Beckhoven D, Annemans L.

Acta Clin Belg. 2018 Apr;73(2):167. doi: 10.1080/17843286.2017.1392091. No abstract available.

PMID:
29560819
8.

The potential health and economic effects of plant-based food patterns in Belgium and the United Kingdom.

Schepers J, Annemans L.

Nutrition. 2018 Apr;48:24-32. doi: 10.1016/j.nut.2017.11.028. Epub 2017 Dec 15.

PMID:
29469016
9.

Resource Use During the Last 6 Months of Life of Individuals Dying with and of Alzheimer's Disease.

Faes K, Cohen J, Annemans L.

J Am Geriatr Soc. 2018 May;66(5):879-885. doi: 10.1111/jgs.15287. Epub 2018 Feb 15.

PMID:
29446066
10.

The health-related social costs of alcohol in Belgium.

Verhaeghe N, Lievens D, Annemans L, Vander Laenen F, Putman K.

BMC Public Health. 2017 Dec 16;17(1):958. doi: 10.1186/s12889-017-4974-4.

11.

'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies.

Annemans L, Packard CJ, Briggs A, Ray KK.

Eur Heart J. 2017 Dec 11. doi: 10.1093/eurheartj/ehx710. [Epub ahead of print] No abstract available.

PMID:
29236976
12.

Further approaches to reduce the cost of renal replacement therapy.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Van Biesen W, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Nov;13(11):720. doi: 10.1038/nrneph.2017.136. Epub 2017 Sep 25. No abstract available.

PMID:
28944776
13.

Development of a prediction model for long-term quality of life in critically ill patients.

Oeyen S, Vermeulen K, Benoit D, Annemans L, Decruyenaere J.

J Crit Care. 2018 Feb;43:133-138. doi: 10.1016/j.jcrc.2017.09.006. Epub 2017 Sep 6.

PMID:
28892669
14.

Variations in hospital costs after traffic injuries: The importance of sociodemographic aspects and comorbidities.

Devos S, Van Belleghem G, Pien K, Hubloue I, Lauwaert I, van Lier T, Annemans L, Putman K.

Injury. 2017 Oct;48(10):2132-2139. doi: 10.1016/j.injury.2017.08.009. Epub 2017 Aug 5.

PMID:
28838595
15.

Applying Quality Indicators For Administrative Databases To Evaluate End-Of-Life Care For Cancer Patients In Belgium.

De Schreye R, Smets T, Annemans L, Deliens L, Gielen B, De Gendt C, Cohen J.

Health Aff (Millwood). 2017 Jul 1;36(7):1234-1243. doi: 10.1377/hlthaff.2017.0199.

PMID:
28679810
16.

Health and budget impact of combined HIV prevention - first results of the BELHIVPREV model.

Vermeersch S, Callens S, De Wit S, Goffard JC, Laga M, Van Beckhoven D, Annemans L.

Acta Clin Belg. 2018 Feb;73(1):54-67. doi: 10.1080/17843286.2017.1339978. Epub 2017 Jul 3.

PMID:
28673201
17.

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Biesen WV, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30. Review.

PMID:
28555652
18.

Economic consequences of legal and illegal drugs: The case of social costs in Belgium.

Lievens D, Vander Laenen F, Verhaeghe N, Putman K, Pauwels L, Hardyns W, Annemans L.

Int J Drug Policy. 2017 Jun;44:50-57. doi: 10.1016/j.drugpo.2017.03.005. Epub 2017 Apr 23.

PMID:
28445835
19.

HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries.

Nicod E, Annemans L, Bucsics A, Lee A, Upadhyaya S, Facey K.

Health Policy. 2017 Mar 28. pii: S0168-8510(17)30084-2. doi: 10.1016/j.healthpol.2017.03.009. [Epub ahead of print]

20.

Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACS.

Bueno H, Pocock S, Medina J, Danchin N, Annemans L, Licour M, Gregson J, Vega AM, van de Werf F.

Rev Esp Cardiol (Engl Ed). 2017 Oct;70(10):817-824. doi: 10.1016/j.rec.2016.12.031. Epub 2017 Mar 11. English, Spanish.

PMID:
28291730
21.

Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL).

Annemans L, Aymé S, Le Cam Y, Facey K, Gunther P, Nicod E, Reni M, Roux JL, Schlander M, Taylor D, Tomino C, Torrent-Farnell J, Upadhyaya S, Hutchings A, Le Dez L.

Orphanet J Rare Dis. 2017 Mar 10;12(1):50. doi: 10.1186/s13023-017-0601-9.

22.

Modified Rankin scale as a determinant of direct medical costs after stroke.

Dewilde S, Annemans L, Peeters A, Hemelsoet D, Vandermeeren Y, Desfontaines P, Brouns R, Vanhooren G, Cras P, Michielsens B, Redondo P, Thijs V.

Int J Stroke. 2017 Jun;12(4):392-400. doi: 10.1177/1747493017691984. Epub 2017 Feb 6.

PMID:
28164742
23.

Methodological Considerations in Social Cost Studies of Addictive Substances: A Systematic Literature Review.

Verhaeghe N, Lievens D, Annemans L, Vander Laenen F, Putman K.

Front Public Health. 2017 Jan 18;4:295. doi: 10.3389/fpubh.2016.00295. eCollection 2016. Review.

24.

Resource use associated with type 2 diabetes in Africa, the Middle East, South Asia, Eurasia and Turkey: results from the International Diabetes Management Practice Study (IDMPS).

Gagliardino JJ, Atanasov PK, Chan JC, Mbanya JC, Shestakova MV, Leguet-Dinville P, Annemans L.

BMJ Open Diabetes Res Care. 2017 Jan 17;5(1):e000297. doi: 10.1136/bmjdrc-2016-000297. eCollection 2017.

25.

The insights of health and welfare professionals on hurdles that impede economic evaluations of welfare interventions.

Schepers J, Plaete J, De Bourdeaudhuij I, Annemans L, Simoens S.

Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):421-429. doi: 10.1080/14737167.2017.1282316. Epub 2017 Jan 25.

PMID:
28092210
26.

Fulfillment of administrative and professional obligations of hospitals and mission motivation of physicians.

Trybou J, Gemmel P, Desmidt S, Annemans L.

BMC Health Serv Res. 2017 Jan 13;17(1):28. doi: 10.1186/s12913-017-1990-0.

27.

Cost-effectiveness and Budget Effect Analysis of a Population-Based Skin Cancer Screening.

Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Annemans L, Brochez L.

JAMA Dermatol. 2016 Dec 14. doi: 10.1001/jamadermatol.2016.4518. [Epub ahead of print]

PMID:
28002834
28.
29.

Critically ill octogenarians and nonagenarians: evaluation of long-term outcomes, posthospital trajectories and quality of life one year and seven years after ICU discharge.

Oeyen S, Vermassen J, Piers R, Benoit D, Annemans L, Decruyenaere J.

Minerva Anestesiol. 2017 Jun;83(6):598-609. doi: 10.23736/S0375-9393.16.11434-8. Epub 2016 Nov 30.

30.

Patient and provider acceptance of telecoaching in type 2 diabetes: a mixed-method study embedded in a randomised clinical trial.

Odnoletkova I, Buysse H, Nobels F, Goderis G, Aertgeerts B, Annemans L, Ramaekers D.

BMC Med Inform Decis Mak. 2016 Nov 9;16(1):142.

31.

Effectiveness of Pricing Strategies on French Fries and Fruit Purchases among University Students: Results from an On-Campus Restaurant Experiment.

Deliens T, Deforche B, Annemans L, De Bourdeaudhuij I, Clarys P.

PLoS One. 2016 Nov 3;11(11):e0165298. doi: 10.1371/journal.pone.0165298. eCollection 2016.

32.

Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure.

Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Brochez L, Annemans L.

Prev Med. 2016 Dec;93:177-182. doi: 10.1016/j.ypmed.2016.10.005. Epub 2016 Oct 3.

PMID:
27713103
33.

Effectiveness of respite care in supporting informal caregivers of persons with dementia: a systematic review.

Vandepitte S, Van Den Noortgate N, Putman K, Verhaeghe S, Verdonck C, Annemans L.

Int J Geriatr Psychiatry. 2016 Dec;31(12):1277-1288. doi: 10.1002/gps.4504. Epub 2016 Jun 1. Review.

PMID:
27245986
34.

Resource Use and Health Care Costs of COPD Patients at the End of Life: A Systematic Review.

Faes K, De Frène V, Cohen J, Annemans L.

J Pain Symptom Manage. 2016 Oct;52(4):588-599. doi: 10.1016/j.jpainsymman.2016.04.007. Epub 2016 Jul 9. Review.

PMID:
27401511
35.

3D-printing techniques in a medical setting: a systematic literature review.

Tack P, Victor J, Gemmel P, Annemans L.

Biomed Eng Online. 2016 Oct 21;15(1):115. Review.

36.

Using linked administrative and disease-specific databases to study end-of-life care on a population level.

Maetens A, De Schreye R, Faes K, Houttekier D, Deliens L, Gielen B, De Gendt C, Lusyne P, Annemans L, Cohen J.

BMC Palliat Care. 2016 Oct 18;15(1):86.

37.

Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis.

Odnoletkova I, Ramaekers D, Nobels F, Goderis G, Aertgeerts B, Annemans L.

PLoS One. 2016 Oct 11;11(10):e0163997. doi: 10.1371/journal.pone.0163997. eCollection 2016.

38.

Economic Impact of Integrated Care Models for Patients with Chronic Diseases: A Systematic Review.

Desmedt M, Vertriest S, Hellings J, Bergs J, Dessers E, Vankrunkelsven P, Vrijhoef H, Annemans L, Verhaeghe N, Petrovic M, Vandijck D.

Value Health. 2016 Sep - Oct;19(6):892-902. doi: 10.1016/j.jval.2016.05.001. Epub 2016 Jun 29. Review.

39.

Costs of drugs for treatment of rheumatic diseases.

Westhovens R, Annemans L.

RMD Open. 2016 Sep 12;2(2):e000259. doi: 10.1136/rmdopen-2016-000259. eCollection 2016.

40.

International patterns of dual antiplatelet therapy duration after acute coronary syndromes.

Bueno H, Pocock S, Danchin N, Annemans L, Gregson J, Medina J, Van de Werf F.

Heart. 2017 Jan 15;103(2):132-138. doi: 10.1136/heartjnl-2016-309509. Epub 2016 Aug 8.

41.

Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer.

Pil L, Fobelets M, Putman K, Trybou J, Annemans L.

Eur J Intern Med. 2016 Jul;32:72-8. doi: 10.1016/j.ejim.2016.03.031. Epub 2016 May 3.

PMID:
27157827
42.

Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry.

Annemans L, Danchin N, Van de Werf F, Pocock S, Licour M, Medina J, Bueno H.

Open Heart. 2016 Feb 24;3(1):e000347. doi: 10.1136/openhrt-2015-000347. eCollection 2016.

43.

Effectiveness of Supporting Informal Caregivers of People with Dementia: A Systematic Review of Randomized and Non-Randomized Controlled Trials.

Vandepitte S, Van Den Noortgate N, Putman K, Verhaeghe S, Faes K, Annemans L.

J Alzheimers Dis. 2016 Apr 8;52(3):929-65. doi: 10.3233/JAD-151011. Review.

PMID:
27079704
44.

The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in Belgium.

Verhaeghe N, De Greve O, Annemans L.

Public Health. 2016 May;134:26-33. doi: 10.1016/j.puhe.2016.01.015. Epub 2016 Feb 26.

PMID:
26921976
45.

Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching.

Odnoletkova I, Goderis G, Nobels F, Fieuws S, Aertgeerts B, Annemans L, Ramaekers D.

Diabet Med. 2016 Jun;33(6):777-85. doi: 10.1111/dme.13092. Epub 2016 Mar 9.

PMID:
26872105
46.

Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation.

Annemans L, Marbaix S, Nackaerts K, Bartsch P.

Prev Med Rep. 2015 Mar 14;2:189-95. doi: 10.1016/j.pmedr.2015.03.004. eCollection 2015.

47.

Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature.

Berm EJ, Looff Md, Wilffert B, Boersma C, Annemans L, Vegter S, Boven JF, Postma MJ.

PLoS One. 2016 Jan 11;11(1):e0146262. doi: 10.1371/journal.pone.0146262. eCollection 2016.

48.

International Diabetes Management Practice Study (Idmps): Resource Use Associated With Type 2 Diabetes In Africa, Middle East, South Asia, Eurasia and Turkey.

Atanasov PK, Chan JC, Gagliardino JJ, Mbanya JC, Shestakova MV, Leguet-Dinville P, Annemans L.

Value Health. 2015 Nov;18(7):A619. doi: 10.1016/j.jval.2015.09.2165. Epub 2015 Oct 20. No abstract available.

49.

Impact of Nurse-Led Telecoaching on the Annual Healthcare Utilization and Costs in People with Type 2 Diabetes in Belgium. Within-Trial Analysis of Health Insurance Data.

Odnoletkova I, Annemans L, Aertgeerts B, Ramaekers D.

Value Health. 2015 Nov;18(7):A602. doi: 10.1016/j.jval.2015.09.2067. Epub 2015 Oct 20. No abstract available.

50.

Resource Use And Health Care Costs Of Copd Patients At The End Of Life: A Systematic Review.

Faes K, De Frène V, Cohen J, Annemans L.

Value Health. 2015 Nov;18(7):A507. doi: 10.1016/j.jval.2015.09.1451. Epub 2015 Oct 20. No abstract available.

Supplemental Content

Loading ...
Support Center